WHO ICTRP trial
Clinical Outcomes and Prognostic Factors to Predict Treatment Response in High…
TCTR20190602002 · Thai Clinical Trials Registry (TCTR) · Not Recruiting
Key facts
| Trial ID | TCTR20190602002 |
|---|---|
| Public title | Clinical Outcomes and Prognostic Factors to Predict Treatment Response in High Risk Neuroblastoma Patients Receiving Topotecan and Cyclophosphamide Containing Induction Regimen: A Prospective Multicenter Study |
| Scientific title | Clinical Outcomes and Prognostic Factors to Predict Treatment Response in High Risk Neuroblastoma Patients Receiving Topotecan and Cyclophosphamide Containing Induction Regimen: A Prospective Multicenter Study |
| Primary sponsor | Phramongkutklao Hospital and College of Medicine |
| Secondary sponsors | The Patronage of Her Royal Highness Princess Soamsawali |
| Registry | Thai Clinical Trials Registry (TCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational |
| Countries | Thailand |
| Conditions | The study is an observational study and aims to evaluate the clinical outcomes and classify relevant prognostic factors to measure induction response among high risk neuroblastoma patients in Thailand high risked neuroblastoma, topotecan… |
| Interventions | All high risk neuroblastoma patients who received topotecan and cyclophosphamide containing chemotherapy regimen as per ThaiPOG high risk neuroblastoma protocol between 2016-2017;Treatment;Neuroblastoma patients |
| Registration date | Feb 6, 2019 |
| Registry page | thaiclinicaltrials.org |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: